IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS - ANVISA Registration 80358430003
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80358430003 and manufactured by CELL MARQUE CORPORATION. The registration is held by INOPAT IMPORTAÇÃO E EXPORTAÇÃO LTDA. with validity until Oct 04, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VENTANA MEDICAL SYSTEM, INC, LEICA BIOSYSTEMS NEWCASTLE LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80358430003
25351284753201034
07440995000150
Company Information
Dates and Status
Oct 04, 2010
04/10/2035
09/18/2025 19:00:01
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
Not specified
10337990034
Jul 02, 2018
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990034
Jul 02, 2018
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
Família Marcador de Carcinoma de Linfoma e Leucemia
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.
80000230044
Dec 26, 2016
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
Família Marcador de Carcinoma de Linfoma e Leucemia
Not specified
80000230036
Dec 26, 2016
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
Família Marcador de Carcinoma de Linfoma e Leucemia
Not specified
80000230044
Dec 26, 2016
VENTANA MEDICAL SYSTEM, INC• United States of America
LEICA BIOSYSTEMS NEWCASTLE LTD• United Kingdom
AGILENT TECHNOLOGIES, INC.• United States of America
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.• Singapore
CELL MARQUE CORPORATION• United States of America
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Anti-CD8 (SP239) Rabbit Monoclonal Primary Antibody
VENTANA MEDICAL SYSTEM, INC
10287411688
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Anti-CD8 (SP239) Rabbit Monoclonal Primary Antibody
Not specified
10287411688
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
Not specified
10337990034
Jul 02, 2018
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990034
Jul 02, 2018
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Família Marcador de Carcinoma de Linfoma e Leucemia
Not specified
80000230036
Dec 26, 2016